Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$923 | $4,932 | -$1,200 | -$9,273 |
| Dep. & Amort. | $0 | $0 | $0 | $667 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $74 | $80 | $0 |
| Change in WC | $264 | $456 | -$164 | $2,225 |
| Other Non-Cash | -$475 | -$8,470 | -$377 | $7,347 |
| Operating Cash Flow | -$1,134 | -$3,007 | -$1,660 | $965 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$204 | $8,707 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$117 | -$224 | $0 | -$1,145 |
| Financing Cash Flow | -$117 | -$428 | $8,707 | -$1,145 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,251 | -$3,435 | $7,047 | -$185 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,322 | $10,757 | $3,710 | $3,895 |
| End Cash | $6,070 | $7,322 | $10,757 | $3,710 |
| Free Cash Flow | -$1,134 | -$3,007 | -$1,660 | $960 |